A P Grigg, J Sasadeusz. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Amyloidosis/drug therapyFemaleHepatitis B/chemically inducedHepatitis B/immunologyHumansImmunosuppressive Agents/adverse effectsKidney Diseases/drug therapyMiddle AgedRecurrenceThalidomide/adverse effects
Substances： See more » Immunosuppressive AgentsThalidomide
Year: 2008 PMID： 18380715 DOI： 10.1111/j.1445-5994.2008.01653.x
Source DB: PubMed Journal: Intern Med J ISSN： 1444-0903 Impact factor: 2.048